On the other hand, CD133 was shown to confer chemoresistance by activation of the AKT/PKB and Bcl-2 cell survival response in hepatoma cells [27], and suppression of the Hedgehog pathway could also sensitize the hepatoma cells to chemotherapeutic agent [28]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.